Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

Also called NCT01135667

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 106 participants (enrolled count) (from the registry)
Sponsor
Lene Holmvang (from the registry)
Registry
  • NCT NCT01135667
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01135667. Randomized; no masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2012-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
Acronym
TAILOR
Condition
Acute Coronary Syndromes
Intervention (Drug)
clopidogrel
Intervention (Drug)
Prasugrel 10 mg
Lead sponsor
Lene Holmvang (class: other)

Record details

Record id
cardio:ct-nct01135667
Content hash
593012e213ba01c6a4cc747b3ef2f2bb7cbf6489990d4198eed7a1820014447c